Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba
Launched by UNIVERSIDAD AUTONOMA DE SAN LUIS POTOSÍ · Jul 5, 2011
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
Pityriasis alba (PA) is a benign inflammatory dermatosis affecting about 5% of infantile population, frequently seen in tropical areas of the world. This entity has received many synonymous such as chronic impetigo and erythema streptogenes, but its actual name was given from Hazen. PA is also considered a minor criterion for the diagnosis of atopic dermatitis. It is characterized by hypopigmented, irregular plaques with well-defined borders, covered by fine scales; it affects mainly face, limbs and occasionally thorax.
Its etiology is still unknown, although infectious mechanisms and vita...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Pityriasis alba with well defined lesions greater than 3 cm2.
- Exclusion Criteria:
- • Diagnosis of Atopic Dermatitis
- • Skin disorders other than Pityriasis alba
- • Systemic disorders
- • Treatment during the last 8 weeks for this condition
About Universidad Autonoma De San Luis Potosí
The Universidad Autónoma de San Luis Potosí (UASLP) is a prestigious higher education institution in Mexico, renowned for its commitment to advancing research and innovation in the biomedical field. With a strong emphasis on interdisciplinary collaboration, UASLP actively engages in clinical trials aimed at improving health outcomes and contributing to the scientific community. The university's experienced faculty and state-of-the-art facilities enable the execution of rigorous clinical research, fostering the development of new therapeutic approaches and enhancing the quality of patient care. Through its clinical trial initiatives, UASLP aims to bridge the gap between research and clinical practice, ultimately benefiting diverse populations and addressing pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Luis Potosi, , Mexico
Patients applied
Trial Officials
Juan P Castanedo-Cazares, MD
Study Chair
Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto". San Luis Potosi, México
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials